SMAD4 and nonpapillary renal cell carcinoma: Along with the positive correlation between pAMPK and nuclear pSMAD2/SMAD4 in IHC, the Western blot result puts forward the idea that pAMPK overexpression phosphorylates SMAD2 and subsequently activates pSMAD2/SMAD4 in ccRCC.